简介：
Overview
This protocol describes the chemical conjugation of the model antigen ovalbumin to an endocytosis receptor-specific antibody for in vivo dendritic cell targeting. The method includes purification of the antibody, chemical conjugation of the antigen, and verification of efficient conjugation.
Key Study Components
Area of Science
- Immunology
- Cell Biology
- Vaccine Development
Background
- The DEC-205 antibody is used for targeted delivery to dendritic cells.
- Ovalbumin (OVA) serves as a model antigen for testing.
- This method allows for flexibility in selecting protein antigens and antibodies.
- It does not rely on genetic fusion, simplifying the conjugation process.
Purpose of Study
- To develop a reliable protocol for antibody-antigen conjugation.
- To enhance in vivo targeting of dendritic cells for immunotherapy.
- To explore applications in anti-tumor vaccination strategies.
Methods Used
- Resuspension of cryo-preserved NLDC 145 cells in ISF-1 medium.
- Incubation of cells at 37 degrees Celsius and 5% carbon dioxide.
- Centrifugation to collect cells at 70% confluency.
- Purification and conjugation of DEC-205 antibody with OVA antigen.
Main Results
- Successful chemical conjugation of DEC-205 to OVA was achieved.
- The protocol was also effective for hepatitis C virus proteins.
- Demonstrated potential for enhancing anti-tumor vaccination approaches.
- Efficient purification of the conjugate was confirmed.
Conclusions
- This protocol provides a versatile method for antibody-antigen conjugation.
- It can be adapted for various antigens beyond OVA.
- The technique holds promise for advancing dendritic cell-targeted therapies.
What is the main advantage of this conjugation protocol?
The protocol allows for flexible selection of protein antigens and antibodies without relying on genetic fusion.
Can this method be used for other antigens?
Yes, the protocol can be adapted for various antigens, including hepatitis C virus proteins.
What type of cells are used in this protocol?
NLDC 145 cells are used for the production of the DEC-205 antibody.
What are the incubation conditions for the cells?
Cells are incubated at 37 degrees Celsius and 5% carbon dioxide.
How is the conjugate verified?
Verification of efficient conjugation is part of the protocol, ensuring successful outcomes.
繁體中文
